Atlas Trials

Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.

Clinical trial NCT02891213 · UNKNOWN

Trial details

NCT number
NCT02891213
Sponsor
CHU de Reims
Status
UNKNOWN
Study type
OBSERVATIONAL
Lupus Erythematosus
Start date
2016-11-01
Primary completion
2017-01-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.